Tuesday, November 5, 2024
HomeTagsNovel Cancer Compounds

Novel Cancer Compounds

Debiopharm Announces Oncology Research Advancements at AACR 2022 for Novel Cancer Compounds and Drug Delivery Technologies

Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics